Longview Partners Guernsey LTD grew its stake in shares of HCA Healthcare Inc (NYSE:HCA) by 9.4% during the second quarter, according to the company in its most recent disclosure with the SEC. The fund owned 9,487,250 shares of the company’s stock after buying an additional 813,474 shares during the quarter. HCA Healthcare makes up 6.2% of Longview Partners Guernsey LTD’s holdings, making the stock its 2nd biggest holding. Longview Partners Guernsey LTD’s holdings in HCA Healthcare were worth $1,282,392,000 as of its most recent filing with the SEC.
Several other institutional investors have also modified their holdings of HCA. Dimensional Fund Advisors LP grew its stake in shares of HCA Healthcare by 3.2% in the fourth quarter. Dimensional Fund Advisors LP now owns 544,838 shares of the company’s stock worth $67,797,000 after purchasing an additional 16,992 shares during the last quarter. Geode Capital Management LLC boosted its position in HCA Healthcare by 10.0% during the fourth quarter. Geode Capital Management LLC now owns 3,414,676 shares of the company’s stock valued at $424,189,000 after acquiring an additional 310,086 shares during the last quarter. Cornerstone Advisors Inc. boosted its position in HCA Healthcare by 19.6% during the first quarter. Cornerstone Advisors Inc. now owns 587 shares of the company’s stock valued at $77,000 after acquiring an additional 96 shares during the last quarter. Stephens Inc. AR boosted its position in HCA Healthcare by 1.9% during the first quarter. Stephens Inc. AR now owns 12,710 shares of the company’s stock valued at $1,657,000 after acquiring an additional 240 shares during the last quarter. Finally, Cetera Advisor Networks LLC bought a new stake in HCA Healthcare during the first quarter valued at $235,000. 70.38% of the stock is currently owned by institutional investors.
Shares of NYSE HCA traded up $0.98 during trading on Friday, hitting $129.67. 9,538 shares of the company traded hands, compared to its average volume of 1,398,365. The business’s fifty day moving average is $126.91 and its 200 day moving average is $129.21. HCA Healthcare Inc has a fifty-two week low of $110.31 and a fifty-two week high of $147.42. The firm has a market capitalization of $44.36 billion, a price-to-earnings ratio of 13.27, a P/E/G ratio of 1.11 and a beta of 0.87.
The business also recently disclosed a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Tuesday, September 3rd will be issued a dividend of $0.40 per share. The ex-dividend date is Friday, August 30th. This represents a $1.60 annualized dividend and a dividend yield of 1.23%. HCA Healthcare’s dividend payout ratio is currently 16.38%.
In related news, major shareholder Patricia F. Elcan acquired 250 shares of the company’s stock in a transaction dated Tuesday, August 6th. The shares were purchased at an average price of $124.10 per share, for a total transaction of $31,025.00. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Kathleen M. Whalen sold 977 shares of the company’s stock in a transaction dated Tuesday, August 13th. The shares were sold at an average price of $127.56, for a total transaction of $124,626.12. Following the transaction, the senior vice president now owns 11,484 shares in the company, valued at approximately $1,464,899.04. The disclosure for this sale can be found here. 2.70% of the stock is currently owned by corporate insiders.
HCA has been the topic of a number of research analyst reports. Zacks Investment Research cut shares of HCA Healthcare from a “buy” rating to a “hold” rating and set a $130.00 price target on the stock. in a research report on Monday, May 27th. UBS Group upped their price target on shares of HCA Healthcare from $172.00 to $181.00 and gave the company a “buy” rating in a research report on Monday, June 24th. Bank of America raised shares of HCA Healthcare from an “underperform” rating to a “neutral” rating and upped their price target for the company from $130.00 to $137.00 in a research report on Friday, September 6th. Stephens set a $150.00 price target on shares of HCA Healthcare and gave the company a “buy” rating in a research report on Wednesday, August 7th. Finally, Mizuho set a $153.00 price target on shares of HCA Healthcare and gave the company a “buy” rating in a research report on Wednesday, July 31st. Three investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. The company currently has an average rating of “Buy” and a consensus target price of $155.29.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Featured Story: Earnings Reports
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.